| 000 | 01839 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516024248.0 | ||
| 264 | 0 | _c20110729 | |
| 008 | 201107s 0 0 spa d | ||
| 022 | _a0210-5705 | ||
| 024 | 7 |
_a10.1016/j.gastrohep.2010.11.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSuárez, Emilio | |
| 245 | 0 | 0 |
_a[Virological response to adefovir dipivoxil predicts the long-term development of resistance in previously untreated patients with HBeAg-negative chronic hepatitis B]. _h[electronic resource] |
| 260 |
_bGastroenterologia y hepatologia _cFeb 2011 |
||
| 300 |
_a69-74 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Resistance, Viral |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B e Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganophosphonates _xtherapeutic use |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGila, Ana | |
| 700 | 1 | _aFigueruela, Blanca | |
| 700 | 1 | _aChueca, Natalia | |
| 700 | 1 | _aMuñoz Rueda, Pilar | |
| 700 | 1 | _aPuche, Beatriz | |
| 700 | 1 | _aFraga, Enrique | |
| 700 | 1 | _aGarcía, Federico | |
| 700 | 1 | _aMartín, Juan Manuel | |
| 700 | 1 | _aAndrade, Raúl J | |
| 700 | 1 | _aNogales, Carmen | |
| 700 | 1 | _aRomero-Gómez, Manuel | |
| 700 | 1 | _aSalmerón, Javier | |
| 773 | 0 |
_tGastroenterologia y hepatologia _gvol. 34 _gno. 2 _gp. 69-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.gastrohep.2010.11.003 _zAvailable from publisher's website |
| 999 |
_c20611323 _d20611323 |
||